2 results
Approved WMOWill not start
Primary objective: To evaluate the safety, tolerability, and maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) of investigational therapies in subjects with metastatic castration-resistant prostate cancer (mCRPC).Secondary objective:*…
Approved WMORecruiting
To assess the safety and tolerability of PLN 74809 in participants with PSC and suspected liver fibrosis